Does anyone know of a study regarding the likely outcomes of delayed ASCT versus ASCT straight after induction therapy? My concern is the long period of unwellness that seems to afflict most patients that undergo the stem cell procedure. Some (not many) report that the melphalan treatment didn't cause them much trouble, but the average person seems to report feeling really unwell for three months and still not completely well for one year. That coupled with relapses in as little as two months and frequently within two years makes me question the value of writing off a year of life, particularly if it can be put off and have good quality of life in the mean time. I retired in the beginning of 2025 and we have not been able to do much because of Friday blood draw/Monday treatment schedule. It sure would be nice to have a break instead of diving right into ill health again, but I want to do what is best for my wife. Thanks!